Potential Therapy for NeuroAIDS Using Soluble TNF Receptor
Author Information
Author(s): Cao Shengbo, Wu Chengxiang, Yang Yongbo, Sniderhan Lynn F, Maggirwar Sanjay B, Dewhurst Stephen, Lu Yuanan
Primary Institution: University of Hawai'i
Hypothesis
A soluble TNF-α antagonist might have potential utility as a neuroprotective effecter molecule.
Conclusion
Lentiviral vector mediated expression of sTNFR-Fc may have potential as a novel therapy for neuroAIDS.
Supporting Evidence
- High-titer lentiviral vectors were prepared, allowing efficient transduction of macrophage/glial and neuronal cell lines.
- Stable secretion of sTNFR-Fc was demonstrated in supernatants from transduced cell lines over 20 passages.
- The secreted protein was shown to protect neuronal cells from TNF-α, HIV-1 Tat-, and gp120-mediated neurotoxicity.
Takeaway
Researchers created a special protein that can help protect brain cells from damage caused by HIV. This protein could be a new way to treat brain problems related to HIV.
Methodology
The study involved constructing a soluble TNF receptor (sTNFR)-Fc fusion protein and testing its expression and protective effects in human macrophage and neuronal cell lines using lentiviral vectors.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website